Olympus Co. (OTCMKTS:OCPNY) – Jefferies Financial Group dropped their FY2022 earnings estimates for shares of Olympus in a report released on Monday, June 7th. Jefferies Financial Group analyst M. Nakanomyo now expects that the company will post earnings of $0.63 per share for the year, down from their previous estimate of $0.64.
Separately, Zacks Investment Research upgraded shares of Olympus from a “sell” rating to a “hold” rating in a research report on Tuesday, May 25th.
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through five segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, Imaging Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, video and other endoscopes system, and repair services.
Recommended Story: What impact do institutional investors have on markets?
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.